Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Receives $27.83 Consensus Target Price from Brokerages
Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Free Report) has received an average recommendation of “Moderate Buy” from the six analysts that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12-month price target […]
Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Free Report) has received an average recommendation of “Moderate Buy” from the six analysts that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12-month price target […]
